MedPath

comparison of therapeutic methods of tinnitus

Phase 3
Conditions
tinnitus.
tinnitus
Registration Number
IRCT201112218438N1
Lead Sponsor
Research deputy of Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

18-75 age? innitus for six month.
Exclusion criteria :menier? flacuating hearing loss? history of epilepcy ? head truma ? brain surgery ? pace maker? using of anticonvulsant or anti psychotic? regular using of banzodiazepine ?pregnant women ? history of suicide? disease that has interaction with tratment .

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of tinnitus. Timepoint: before treatment, after treatment ,4week after treatment. Method of measurement: Visual analog scale, tinnitus questionnaire.
Secondary Outcome Measures
NameTimeMethod
Complication including headache. Timepoint: after treatment. Method of measurement: check list.;Complication including vertigo. Timepoint: after treatment. Method of measurement: check list.
© Copyright 2025. All Rights Reserved by MedPath